📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistance. (2015)

First Author: Munir S

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jac/dku474

PubMed Identifier: 25414202

Publication URI: http://europepmc.org/abstract/MED/25414202

Type: Journal Article/Review

Volume: 70

Parent Publication: The Journal of antimicrobial chemotherapy

Issue: 3

ISSN: 0305-7453